Acquired Genomic Alterations From First-Line Anti-EGFR Chemotherapy in Advanced Colorectal Cancer: Improving Study Design and Data Analysis
- PMID: 36595728
- DOI: 10.1200/JCO.22.02296
Acquired Genomic Alterations From First-Line Anti-EGFR Chemotherapy in Advanced Colorectal Cancer: Improving Study Design and Data Analysis
Comment in
-
Reply to Y. Yu et al.J Clin Oncol. 2023 Mar 1;41(7):1495-1496. doi: 10.1200/JCO.22.02588. Epub 2023 Jan 3. J Clin Oncol. 2023. PMID: 36595731 No abstract available.
Comment on
-
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance).J Clin Oncol. 2023 Jan 20;41(3):472-478. doi: 10.1200/JCO.22.00365. Epub 2022 Sep 6. J Clin Oncol. 2023. PMID: 36067452 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
